| Subretinal electronic chips allow blind patients to read letters and combine them to words E Zrenner, KU Bartz-Schmidt, H Benav, D Besch, A Bruckmann, VP Gabel, ... Proceedings of the Royal Society B: Biological Sciences 278 (1711), 1489-1497, 2011 | 1027 | 2011 |
| Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn E Yoeruek, F Ziemssen, S Henke‐Fahle, O Tatar, A Tura, S Grisanti, ... Acta Ophthalmologica 86 (3), 322-328, 2008 | 206 | 2008 |
| High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates I Bonzheim, S Giese, C Deuter, D Süsskind, M Zierhut, M Waizel, ... Blood, The Journal of the American Society of Hematology 126 (1), 76-79, 2015 | 204 | 2015 |
| Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization Q Zhu, F Ziemssen, S Henke-Fahle, O Tatar, P Szurman, S Aisenbrey, ... Ophthalmology 115 (10), 1750-1755. e1, 2008 | 199 | 2008 |
| Spatial resolution and perception of patterns mediated by a subretinal 16-electrode array in patients blinded by hereditary retinal dystrophies R Wilke, VP Gabel, H Sachs, KUB Schmidt, F Gekeler, D Besch, ... Investigative ophthalmology & visual science 52 (8), 5995-6003, 2011 | 181 | 2011 |
| Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells MS Spitzer, B Wallenfels-Thilo, A Sierra, E Yoeruek, S Peters, ... British Journal of Ophthalmology 90 (10), 1316-1321, 2006 | 180 | 2006 |
| Macular translocation with 360 retinotomy for exudative age-related macular degeneration S Aisenbrey, BA Lafaut, P Szurman, S Grisanti, C Lüke, R Krott, ... Archives of Ophthalmology 120 (4), 451-459, 2002 | 176 | 2002 |
| Z-suture: a new knotless technique for transscleral suture fixation of intraocular implants P Szurman, K Petermeier, S Aisenbrey, MS Spitzer, GB Jaissle British Journal of Ophthalmology 94 (2), 167-169, 2010 | 165 | 2010 |
| Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema MS Spitzer, F Ziemssen, E Yoeruek, K Petermeier, S Aisenbrey, ... Journal of Cataract & Refractive Surgery 34 (1), 70-75, 2008 | 153 | 2008 |
| Safety profile of bevacizumab on cultured human corneal cells E Yoeruek, MS Spitzer, O Tatar, S Aisenbrey, KU Bartz-Schmidt, ... Cornea 26 (8), 977-982, 2007 | 151 | 2007 |
| Successful long-term implantation of electrically inactive epiretinal microelectrode arrays in rabbits P Walter, P Szurman, M Vobig, H Berk, HC LUDTKE-HANDJERY, ... Retina 19 (6), 546-552, 1999 | 151 | 1999 |
| Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients D Besch, H Sachs, P Szurman, D Gülicher, R Wilke, S Reinert, E Zrenner, ... British Journal of Ophthalmology 92 (10), 1361-1368, 2008 | 148 | 2008 |
| Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration S Aisenbrey, F Ziemssen, M Völker, F Gelisken, P Szurman, G Jaissle, ... Graefe's Archive for Clinical and Experimental Ophthalmology 245, 941-948, 2006 | 142 | 2006 |
| One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion GB Jaissle, M Leitritz, F Gelisken, F Ziemssen, KU Bartz-Schmidt, ... Graefe's Archive for Clinical and Experimental Ophthalmology 247, 27-33, 2009 | 141 | 2009 |
| Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study S Grisanti, P Szurman, M Warga, R Kaczmarek, F Ziemssen, O Tatar, ... Investigative ophthalmology & visual science 46 (1), 191-196, 2005 | 137 | 2005 |
| Virtual reality training improves wet-lab performance of capsulorhexis: results of a randomized, controlled study EM Feudner, C Engel, IM Neuhann, K Petermeier, KU Bartz-Schmidt, ... Graefe's Archive for Clinical and Experimental Ophthalmology 247, 955-963, 2009 | 134 | 2009 |
| Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells MS Spitzer, E Yoeruek, A Sierra, B Wallenfels-Thilo, U Schraermeyer, ... Graefe's Archive for Clinical and Experimental Ophthalmology 245, 1837-1842, 2007 | 130 | 2007 |
| Decellularization of porcine corneas and repopulation with human corneal cells for tissue‐engineered xenografts E Yoeruek, T Bayyoud, C Maurus, J Hofmann, MS Spitzer, ... Acta ophthalmologica 90 (2), e125-e131, 2012 | 129 | 2012 |
| Intraocular lens power calculation and optimized constants for highly myopic eyes K Petermeier, F Gekeler, A Messias, MS Spitzer, W Haigis, P Szurman Journal of Cataract & Refractive Surgery 35 (9), 1575-1581, 2009 | 127 | 2009 |
| The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute C Schramm, MS Spitzer, S Henke-Fahle, G Steinmetz, K Januschowski, ... Investigative ophthalmology & visual science 53 (2), 613-621, 2012 | 118 | 2012 |
